Review articlePublished 17 Sep 2018
Different Drugs are Tried to Counteract the Cardio Toxicity of Doxorubicin and their Suggested Mechanisms: A Review Article
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Doxorubicin remains an important drug of chemotherapeutic agents. Unfortunately, its efficacy in treating in different types of cancer cancer is limited by a cumulative dose-dependent cardiotoxicity, which can cause irreversible heart problems and cardiomyopathy. It is very critical to understand the mechanism of doxorubicin induced cardiotoxicity to counteract this problem. Oxidative stress, apoptosis, autophagy and senescence are the most important causes for its cardiotoxicity, therefore, different drugs like melatonin, metformine, captopril, rosuvasatatin and omega-3 can be considered feasible candidates to protect against its cardiotoxicity. Therefore, the mechanisms of its cardiotoxicity as well as different drugs used to counteract it are discussed in this review.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Medical Oncology
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Ibrahim El-Sayed”
